In Frankfurt, Deutsche Telekom led the DAX higher on investors' first opportunity to react to positive Thursday earning figures from affiliate T-Mobile USA (TMUS).
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.
Obamacare? Trumpcare? These stocks don't care.